AN2 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	33.5	15.65	27.22	12.1	4.07	5.6
Short-Term Investments	59.92	91.65	68.84	46.46	-	-
Cash & Short-Term Investments	93.43	107.3	96.06	58.56	4.07	5.6
Cash Growth	-24.55%	11.70%	64.05%	1338.70%	-27.30%	-
Prepaid Expenses	3.26	3.21	2.51	1.55	0.16	0.02
Other Current Assets	-	-	0.05	-	-	0.08
Total Current Assets	97.69	110.51	98.62	60.11	4.23	5.7
Long-Term Investments	-	27.19	3.22	3.49	-	-
Long-Term Deferred Charges	-	-	-	1.72	-	-
Other Long-Term Assets	-	1.04	0.72	-	-	-
Total Assets	97.69	138.74	102.56	65.32	4.23	5.7
Accounts Payable	1.71	2.68	2.12	1.06	0.13	0.05
Accrued Expenses	7.03	10.7	5.01	2	1.31	0.11
Current Portion of Leases	-	-	0.05	-	-	-
Other Current Liabilities	1.28	0.67	0.01	0.33	0.01	-
Total Current Liabilities	10.02	14.04	7.19	3.4	1.46	0.16
Long-Term Debt	-	-	-	-	-	0.73
Other Long-Term Liabilities	-	-	0	0.01	0.02	-
Total Liabilities	10.02	14.04	7.19	3.41	1.48	0.89
Additional Paid-In Capital	285.81	278.88	185.47	-	-	-
Retained Earnings	-198.25	-154.46	-89.72	-47.38	-20.32	-5.8
Comprehensive Income & Other	0.11	0.28	-0.37	-0.03	-	-
Total Common Equity	87.67	124.7	95.37	-47.41	-20.32	-5.8
Shareholders' Equity	87.67	124.7	95.37	61.91	2.75	4.81
Total Liabilities & Equity	97.69	138.74	102.56	65.32	4.23	5.7
Total Debt	-	-	0.05	-	-	0.73
Net Cash (Debt)	93.43	107.3	96.01	58.56	4.07	4.87
Net Cash Growth	-24.55%	11.76%	63.96%	1338.70%	-16.43%	-
Net Cash Per Share	3.13	4.55	6.26	22.20	1.58	1.91
Filing Date Shares Outstanding	29.88	29.77	19.4	2.73	2.71	2.55
Total Common Shares Outstanding	29.87	29.74	19.4	2.73	2.71	2.55
Working Capital	87.67	96.46	91.44	56.71	2.78	5.54
Book Value Per Share	2.94	4.19	4.92	-17.36	-7.50	-2.27
Tangible Book Value	87.67	124.7	95.37	-47.41	-20.32	-5.8
Tangible Book Value Per Share	2.94	4.19	4.92	-17.36	-7.50	-2.27

Source: S&P Capital IQ. Standard template. Financial Sources.